138 related articles for article (PubMed ID: 36158480)
1. Short- (30-90 days) and mid-term (1-3 years) outcomes and prognostic factors of patients with esophageal cancer undergoing surgical treatments.
Shi MK; Mei YQ; Shi JL
World J Clin Cases; 2022 Aug; 10(22):7708-7719. PubMed ID: 36158480
[TBL] [Abstract][Full Text] [Related]
2. A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma.
Zhang Z; Xu L; Di X; Zhang C; Ge X; Sun X
Ann Palliat Med; 2019 Nov; 8(5):708-716. PubMed ID: 31865731
[TBL] [Abstract][Full Text] [Related]
3. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract][Full Text] [Related]
4. Impact of palliative therapies in metastatic esophageal cancer patients not receiving chemotherapy.
Kim S; DiPeri TP; Guan M; Placencio-Hickok VR; Kim H; Liu JY; Hendifar A; Klempner SJ; Nipp R; Gangi A; Burch M; Waters K; Cho M; Chao J; Atkins K; Kamrava M; Tuli R; Gong J
World J Gastrointest Surg; 2020 Sep; 12(9):377-389. PubMed ID: 33024512
[TBL] [Abstract][Full Text] [Related]
5. Association of Tumor-Associated Collagen Signature With Prognosis and Adjuvant Chemotherapy Benefits in Patients With Gastric Cancer.
Chen D; Chen H; Chi L; Fu M; Wang G; Wu Z; Xu S; Sun C; Xu X; Lin L; Cheng J; Jiang W; Dong X; Lu J; Zheng J; Chen G; Li G; Zhuo S; Yan J
JAMA Netw Open; 2021 Nov; 4(11):e2136388. PubMed ID: 34846524
[TBL] [Abstract][Full Text] [Related]
6. Clinical Prognostic Factors for Patients With Esophageal Cancer Treated With Definitive Chemoradiotherapy.
Favareto SL; Sousa CF; Pinto PJ; Ramos H; Chen MJ; Castro DG; Silva ML; Gondim G; Pellizzon ACA; Fogaroli RC
Cureus; 2021 Oct; 13(10):e18894. PubMed ID: 34820218
[TBL] [Abstract][Full Text] [Related]
7. Effect of different surgical approaches on the prognosis of patients with postoperative radiotherapy for stage IIB-IVA esophageal squamous cancer.
Gao M; Zhu Y; Gu Y; Shi Z; Wu J; Chang H; Song J
World J Surg Oncol; 2022 Aug; 20(1):271. PubMed ID: 36038943
[TBL] [Abstract][Full Text] [Related]
8. Radical esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma followed by adjuvant radiotherapy with or without chemotherapy: Which is more beneficial?
Zou B; Tu Y; Liao D; Xu Y; Wang J; Huang M; Ren L; Zhu J; Gong Y; Liu Y; Zhou L; Zhou X; Peng F; Lu Y
Thorac Cancer; 2020 Mar; 11(3):631-639. PubMed ID: 31943824
[TBL] [Abstract][Full Text] [Related]
9. The impact of the nodal status on the overall survival of non-surgical patients with esophageal squamous cell carcinoma.
Zhao Z; Zhang Y; Wang P; Wang X; Li M
Radiat Oncol; 2019 Sep; 14(1):161. PubMed ID: 31481064
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic value of the tumor deposit in N0 gastric cancer by propensity score matching analysis].
Zhi C; Yang W; Li N; Zhang Z; Hua Y; Liu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):172-179. PubMed ID: 30799540
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
[TBL] [Abstract][Full Text] [Related]
12. Clinical and pathological prognostic factors in patients with stage III-IVA-B oral squamous cell carcinoma.
Kravets OV; Protsyk VS; Burtyn OV; Hlynin OV; Hurianov VH
Exp Oncol; 2019 Jun; 41(2):144-147. PubMed ID: 31262157
[TBL] [Abstract][Full Text] [Related]
13. [Factors affecting on long-time survival in patients with stage Ⅲ thoracic esophageal carcinoma after esophagectomy].
Yang Q; Wang YX; He M; Li J; Qi Z; Zhu SC; Qiao XY
Zhonghua Zhong Liu Za Zhi; 2016 Jul; 38(7):530-7. PubMed ID: 27531268
[TBL] [Abstract][Full Text] [Related]
14. Prognostic evaluation of esophageal cancer patients with stages I-III.
Qiu MJ; Yang SL; Wang MM; Li YN; Jiang X; Huang ZZ; Xiong ZF
Aging (Albany NY); 2020 Jul; 12(14):14736-14753. PubMed ID: 32701062
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
[No Abstract] [Full Text] [Related]
16. Association Between Surgical Margins Larger Than 1 cm and Overall Survival in Patients With Merkel Cell Carcinoma.
Andruska N; Fischer-Valuck BW; Mahapatra L; Brenneman RJ; Gay HA; Thorstad WL; Fields RC; MacArthur KM; Baumann BC
JAMA Dermatol; 2021 May; 157(5):540-548. PubMed ID: 33760021
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
[TBL] [Abstract][Full Text] [Related]
18. Impact of sex on the prognosis of patients with esophageal squamous cell cancer underwent definitive radiotherapy: a propensity score-matched analysis.
Luo HS; Xu HY; Du ZS; Li XY; Wu SX; Huang HC; Lin LX
Radiat Oncol; 2019 May; 14(1):74. PubMed ID: 31046792
[TBL] [Abstract][Full Text] [Related]
19. The impact of adjuvant therapy on survival for node-negative esophageal squamous cell carcinoma: a propensity score-matched analysis.
Deng X; He W; Jiang Y; Deng S; Mao T; Leng X; Luo Q; Zheng K; Han Y
Ann Transl Med; 2021 Jun; 9(12):998. PubMed ID: 34277798
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Prognostic Analysis of 315 Stage I-IVa Esophageal Cancer Patients Treated with Simultaneous Integrated Boost-Intensity-Modulated Radiation Therapy.
Cai P; Yang Y; Li DJ
Cancer Manag Res; 2021; 13():6969-6975. PubMed ID: 34522139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
